<DOC>
	<DOCNO>NCT00414011</DOCNO>
	<brief_summary>The purpose study prospective , double-blinded , randomized trial compare rate heal follow PRK use two commercially available 4th generation fluoroquinolones , moxifloxacin gatifloxacin .</brief_summary>
	<brief_title>Comparison Effect 4th Generation Fluoroquinolones , Gatifloxacin Moxifloxacin , Epithelial Healing Following Photorefractive Keratectomy ( PRK ) , A Substudy : Initial Evaluation Excimer Laser Keratorefractive Surgery U.S. Army Personnel ( WU # 2335-99 )</brief_title>
	<detailed_description />
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Manifest refraction spherical equivalent ( MSE ) 6.00 diopter ( D ) spectacle plane refractive cylinder 3.00D . Concurrent topical systemic medication may impair heal include corticosteroid , antimetabolite , isotretinoin , amiodarone hydrochloride and/ sumatripin . Patients know sensitivity inappropriate responsiveness medication use postoperative course . Anterior basement membrane dystrophy . History recurrent epithelial erosion . Significant dry eye ( symptomatic sith Schirmer &lt; 5mm 5 minute ) Other corneal epithelial disorder heal abnormality</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Removal corneal epithelium follow excimer laser treatment prk</keyword>
</DOC>